Uram, Ł.; Pieńkowska, N.; Misiorek, M.; Szymaszek, Ż.; Twardowska, M.; Siorek, M.; Wołowiec, S.
Repurposed Drugs Celecoxib and Fmoc-L-Leucine Alone and in Combination as Temozolomide-Resistant Antiglioma Agents—Comparative Studies on Normal and Immortalized Cell Lines, and on C. elegans. Int. J. Mol. Sci. 2024, 25, 3226.
https://doi.org/10.3390/ijms25063226
AMA Style
Uram Ł, Pieńkowska N, Misiorek M, Szymaszek Ż, Twardowska M, Siorek M, Wołowiec S.
Repurposed Drugs Celecoxib and Fmoc-L-Leucine Alone and in Combination as Temozolomide-Resistant Antiglioma Agents—Comparative Studies on Normal and Immortalized Cell Lines, and on C. elegans. International Journal of Molecular Sciences. 2024; 25(6):3226.
https://doi.org/10.3390/ijms25063226
Chicago/Turabian Style
Uram, Łukasz, Natalia Pieńkowska, Maria Misiorek, Żaneta Szymaszek, Magdalena Twardowska, Michał Siorek, and Stanisław Wołowiec.
2024. "Repurposed Drugs Celecoxib and Fmoc-L-Leucine Alone and in Combination as Temozolomide-Resistant Antiglioma Agents—Comparative Studies on Normal and Immortalized Cell Lines, and on C. elegans" International Journal of Molecular Sciences 25, no. 6: 3226.
https://doi.org/10.3390/ijms25063226
APA Style
Uram, Ł., Pieńkowska, N., Misiorek, M., Szymaszek, Ż., Twardowska, M., Siorek, M., & Wołowiec, S.
(2024). Repurposed Drugs Celecoxib and Fmoc-L-Leucine Alone and in Combination as Temozolomide-Resistant Antiglioma Agents—Comparative Studies on Normal and Immortalized Cell Lines, and on C. elegans. International Journal of Molecular Sciences, 25(6), 3226.
https://doi.org/10.3390/ijms25063226
